| Mon, Nov 9, 2009 | | • | Drug Manufacturers M&A Success Rate Examined By Morningstar Healthcare Strategist
Wall Street Transcript (Mon 3:55pm)
| | Fri, Nov 6, 2009 | | • | Generic Drugs' New Frontier
Investor's Business Daily (Fri, Nov 6)
| | • | Specialty Pharma Stock Picks From David Amsellem Of Piper Jaffray
Wall Street Transcript (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | • | Indian Pharmaceutical Stock Picks From Citi Investment Research: The Sub Continent Goes Global WIth Drug Manufacturing Partnerships
Wall Street Transcript (Thu, Nov 5)
| | • | MYLAN INC. Financials
EDGAR Online Financials (Thu, Nov 5)
| | • | Chinese Companies Traded On US Stock Exchanges Provide Deep Value For Investors According To First Wilshire Securities
Wall Street Transcript (Thu, Nov 5)
| | • | A 130 / 30 Global Pharma Strategy
at Seeking Alpha (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | • | Teva Reports Strong Quarter
Zacks.com (Wed, Nov 4)
| | Tue, Nov 3, 2009 | | • | Nice Quarter, Teva. What Will You Buy Next?
at Motley Fool (Tue, Nov 3)
| | • | UPDATE - Teva Q3 profit rises as Copaxone sales jump
at Reuters (Tue, Nov 3)
| | • | Obamacare Positive To Net Neutral For Pharmaceutical Industry According To Analysis By Morningstar Expert
Wall Street Transcript (Tue, Nov 3)
| | Fri, Oct 30, 2009 | | • | [$$] Mylan Again Sues Pittsburgh Post-Gazette
at The Wall Street Journal Online (Fri, Oct 30)
| | • | MYLAN INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Oct 30)
| | Thu, Oct 29, 2009 | | • | Mylan Beats, Raises Outlook
Zacks.com (Thu, Oct 29)
| | • | Markets rebound by noon Thursday; Kennametal up 11 percent
at bizjournals.com (Thu, Oct 29)
| | • | Biotech Stocks: BioMarin, Human Genome lead drug stocks higher
at MarketWatch (Thu, Oct 29)
| | • | UPDATE - Mylan 3rd-qtr results top estimates; shares rise
at Reuters (Thu, Oct 29)
| | • | Mylan reports 3Q loss on revenue drop, charge
AP (Thu, Oct 29)
| | • | Q3 2009 Mylan Inc. Earnings Release - Before Market Open
CCBN (Thu, Oct 29)
| | • | Mylan Laboratories swings to loss, raises outlook
at MarketWatch (Thu, Oct 29)
|
Add MYL News to My Yahoo!:
 
| |
|
2.03% Nasdaq 0.00%
Headlines
